Solid Biosciences (SLDB) Profit After Tax (2017 - 2026)
Quarterly results put Profit After Tax at -$56.7 million for Q1 2026, down 44.44% from a year ago — trailing twelve months through Mar 2026 was -$191.8 million (down 37.28% YoY), and the annual figure for FY2025 was -$174.3 million, down 39.78%.
Solid Biosciences has reported Profit After Tax over the past 10 years, most recently at -$56.7 million for Q1 2026.
- Profit After Tax reached -$56.7 million in Q1 2026 per SLDB's latest filing, down from -$49.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$15.2 million in Q4 2022 and bottomed at -$56.7 million in Q1 2026.
- Median Profit After Tax over the past 5 years was -$25.3 million (2022), compared with a mean of -$31.6 million.
- Peak annual rise in Profit After Tax hit 19.18% in 2024, while the deepest fall reached 109.64% in 2024.
- Over 5 years, Profit After Tax stood at -$15.2 million in 2022, then crashed by 34.12% to -$20.3 million in 2023, then plummeted by 109.64% to -$42.6 million in 2024, then dropped by 16.81% to -$49.8 million in 2025, then decreased by 14.02% to -$56.7 million in 2026.
- Business Quant data shows Profit After Tax for SLDB at -$56.7 million in Q1 2026, -$49.8 million in Q4 2025, and -$45.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -56.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.74 Mn |
| Dec 31, 2025 | -49.76 Mn |
| Sep 30, 2025 | -45.78 Mn |
| Jun 30, 2025 | -39.48 Mn |
| Mar 31, 2025 | -39.28 Mn |
| Dec 31, 2024 | -42.60 Mn |
| Sep 30, 2024 | -32.73 Mn |
| Jun 30, 2024 | -25.07 Mn |
| Mar 31, 2024 | -24.30 Mn |
| Dec 31, 2023 | -20.32 Mn |
| Sep 30, 2023 | -20.98 Mn |
| Jun 30, 2023 | -24.63 Mn |
| Mar 31, 2023 | -30.07 Mn |
| Dec 31, 2022 | -15.15 Mn |
| Sep 30, 2022 | -20.41 Mn |
| Jun 30, 2022 | -25.09 Mn |
| Mar 31, 2022 | -25.33 Mn |
| Dec 31, 2021 | -18.61 Mn |
| Sep 30, 2021 | -17.98 Mn |
| Jun 30, 2021 | -18.70 Mn |
| Mar 31, 2021 | -16.90 Mn |
| Dec 31, 2020 | -21.36 Mn |
| Sep 30, 2020 | -21.25 Mn |
| Jun 30, 2020 | -18.99 Mn |
| Mar 31, 2020 | -26.69 Mn |
| Dec 31, 2019 | -31.86 Mn |
| Sep 30, 2019 | -29.26 Mn |
| Jun 30, 2019 | -26.53 Mn |
| Mar 31, 2019 | -29.58 Mn |
| Dec 31, 2018 | -21.92 Mn |
| Sep 30, 2018 | -19.02 Mn |
| Jun 30, 2018 | -17.98 Mn |
| Mar 31, 2018 | -15.88 Mn |
| Dec 31, 2017 | -14.49 Mn |
| Sep 30, 2017 | -13.51 Mn |
| Jun 30, 2017 | -11.31 Mn |
| Mar 31, 2017 | -12.82 Mn |